Assignee
SLBIGEN INC
KR·0 granted patents·7 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
7 records- 0171US2022401518A1Mesenchymal stem cell expressing hepatocyte growth factor, and use thereofSLBIGEN INC·Filed 2022·Application pending·0 cites
- 0269US2022401491A1Mesenchymal stem cell expressing trail and cd, and use thereofSLBIGEN INC·Filed 2022·Application pending·0 cites
- 0357US2022333079A1Genetically modified nk cell line transduced with gene encoding novel chimeric antigen receptor and use thereofSLBIGEN INC·Filed 2020·Application pending·0 cites
- 0456US2019038676A1Mesenchymal stem cell expressing trail and cd, and use thereofSLBIGEN INC·Filed 2017·Application pending·0 cites
- 0553US2019038717A1Mesenchymal stem cell expressing hepatocyte growth factor, and use thereofSLBIGEN INC·Filed 2017·Application pending·0 cites
- 0647US2021155663A1Mesenchymal stem cells expressing brain-derived neurotrophic factor and use thereofSLBIGEN INC·Filed 2019·Application pending·0 cites
- 0730US2019231862A1Gene vaccine for preventing and treating severe fever with thrombocytopenia syndromeSLBIGEN INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SLBIGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →